Lifeboat Foundation

Alphabet, parent holding company of Google, has announced that it’s cutting around 6% of its global workforce.

In an open letter published by Google and Alphabet CEO Sundar Pichai, the narrative followed a similar trajectory to that of other companies that have downsized in recent months, noting that the company had “hired for a different economic reality” than what it’s up against today.

Put simply, it had bolstered its workforce during the pandemic-driven digital boom times, but it’s now having to reverse course as the world curtails its spending in the face of economic headwinds.

Google CEO Sundar Pichai announced the news in an email to staff, saying the company needed to focus on key priorities — like artificial intelligence.

Google is cutting approximately 12,000 jobs — the latest technology firm to initiate significant layoffs as inflation rises and global markets brace for a downturn.

Google SEO Sundar Pichai announced the cuts in an email to staff on Friday and a blog post. The job losses constitute around 6 percent of Google’s global workforce, compared to recent layoffs at Microsoft (10,000 jobs or 5 percent of the workforce), Amazon (18,000 jobs / 6 percent), and Meta (11,000 / 13 percent).

Continue reading “Google cuts 12,000 jobs in latest round of big tech layoffs” »

The New York Times reports Google founders Larry Page and Sergey Brin have discussed its response to ChatGPT, with plans to launch over 20 AI products this year, including a demo of its own search chatbot.

The recent launch of OpenAI’s AI chatbot ChatGPT has raised alarms within Google, according to reports from The.

As recently as December, we’d heard Google execs were worried that despite investing heavily in AI technology, moving too fast to roll it out could harm the company’s reputation.

Continue reading “Google is freaking out about ChatGPT” »

This video explains what are mutations?

Thank You For Watching.

Continue reading “What Are Mutations and Why They’re So Interesting” »

The wetware in a casket of bone that we each carry on our shoulders is 1 million times more efficient than the AI models run by services like ChatGPT, Stable Diffusion, or DALL-E.

In this TechFirst with John Koetsier we chat for a second time with Gordon Wilson, CEO of Rain AI, which is building a neuromorphic artificial brain simulating the structure of our biological brains, and aiming at 10,000 to 100,000 greater energy efficiency than current AI architectures.

Continue reading “Our brains are 1 million times more efficient than ChatGPT: chatting with Gordon Wilson of Rain AI” »

Papers:
Black Hole Energy.

Penrose process for a charged black hole in a uniform.
magnetic field https://arxiv.org/pdf/2106.15010.pdf.

Continue reading “What Constitutes Real Starships?” »

DARPA has trained one of its robots to identify humans. There’s just one little problem: The robot is cartoonishly easy to confuse.

Summary: Researchers have developed a new family of nano-scale capsules capable of carrying CRISPR gene editing tools to different organs of the body before harmlessly dissolving. The capsules were able to enter the brains of mice and successfully edit a gene associated with Alzheimer’s disease.

Source: University of Wisconsin-Madison.

Gene therapies have the potential to treat neurological disorders like Alzheimer’s and Parkinson’s diseases, but they face a common barrier — the blood-brain barrier.

Dual-action cell therapy engineered to eliminate established tumors and train the immune system to eradicate primary tumor and prevent cancer’s recurrence. Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, investigators have developed a new cell therapy approach to eliminate established tumors and induce long-term immunity, training the immune system so that it can prevent cancer from recurring. The team tested their dual-action, cancer-killing vaccine in an advanced mouse model of the deadly brain cancer glioblastoma, with promising results. Findings are published in Science Translational Medicine.